Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ivivi Technologies was a medical technology company that specialized in the development and commercialization of non-invasive electrotherapeutic devices. The company's proprietary platform utilized Pulsed Electromagnetic Field (PEMF) technology designed to enhance the body's natural anti-inflammatory response by modulating nitric oxide signaling. Its flagship product, SofPulse, received FDA clearance for the treatment of post-operative pain and edema and was notably licensed to Allergan for use in plastic surgery. Beyond acute pain, the company explored applications for its technology in chronic wound healing and osteoarthritis. In 2010, Ivivi Technologies completed an asset sale of its medical business to Ivivi Health Sciences, LLC, effectively transitioning its technology to a private entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ivivi Technologies.